αv- and β1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients

Gynecologic Oncology

Volumn 90, Issue 2, 2003, Pages 248-257

  Davidson, Ben ^a   Goldberg, Iris ^b,c   Reich, Reuven ^d,f   Tell, Liora ^b,c   Dong, Hiep Phuc ^a   Trope', Claes G ^a,e   Risberg, Bjørn ^a   Kopolovic, Juri ^b,c  

^a UNIVERSITY OF OSLO   (Norway)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Adhesion molecules; Immunohistochemistry; Integrins; mRNA in situ hybridization; Ovarian carcinoma; Serous effusions

Indexed keywords

ALPHA5 INTEGRIN; BASIC FIBROBLAST GROWTH FACTOR; BETA1 INTEGRIN; GELATINASE B; MESSENGER RNA; PROTEIN; PROTEIN EMMPRIN; PROTEIN SUBUNIT; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG; CD51 ANTIGEN; TUMOR MARKER;

ARTICLE; CANCER PATIENT; CARCINOMA CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; EFFUSION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; METASTASIS; OVARY CARCINOMA; PATHOLOGY; PERITONEAL FLUID; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR; TUMOR BIOPSY; ADULT; AGED; ASCITES FLUID; BIOSYNTHESIS; COHORT ANALYSIS; GENETICS; METABOLISM; MIDDLE AGED; OVARY TUMOR;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD29; ASCITIC FLUID; COHORT STUDIES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTEGRIN ALPHAV; MIDDLE AGED; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 0042922958     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-8258(03)00321-4     Document Type: Article

References (39)

1. Ruoslahti E. Integrins. J Clin Invest. 87:1991;1-5.
2. Hood J.D., Cheresh D.A. Role of integrins in cell invasion and migration. Nature Rev. 2:2002;91-100.
3. Sanders R.J., Mainiero F., Giancotti F.P. The role of integrins in tumorigenesis and metastasis. Cancer Invest. 16:1998;329-344.
4. Albelda S.M. Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest. 68:1993;4-17.
5. Clezardin P. Recent insights into the role of integrins in cancer metastasis. Cell Mol Life Sci. 54:1998;541-548.
6. Varner J.A., Cheresh D.A. Integrins and cancer. Curr Opin Cell Biol. 8:1996;724-730.
7. Heino J. Biology of tumor cell invasion interplay of cell adhesion and matrix degradation . Int J Cancer. 65:1996;717-722.
8. Greenlee R.T., Hill-Harmon M.B., Murray T., Thun M. Cancer statistics, 2001. CA Cancer J Clin. 51:2001;15-36.
9. Moser T.L., Pizzo S.V., Bafetti L.M., Fishman D.A., Stack M.S. Evidence for preferential adhesion of ovarian epithelial carcinoma cells to type I collagen mediated by the α2β1 integrin. Int J Cancer. 67:1996;695-701.
10. Cruet S., Salamanca C., Mitchell G.W.E., Auersperg N. αvβ3 and vitronectin expression by normal ovarian surface epithelial cells role in cell adhesion and cell proliferation . Gynecol Oncol. 75:1999;254-260. (gyno.1999.5572).
11. Carreiras F., Rigot V., Cruet S., Andre F., Gauduchon P., Marvaldi J. Migration properties of the human ovarian adenocarcinoma cell line IGROV1 importance of αvβ3 integrins and vitronectin . Int J Cancer. 80:1999;285-294.
12. Cannistra S.A., Ottensmeier C., Niloff J., Orta B., DiCarlo J. Expression and function of β1 and αvβ3 integrins in ovarian cancer. Gynecol Oncol. 58:1995;216-225.
13. Strobel T., Cannistra S.A. β1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro. Gynecol Oncol. 73:1999;362-367.
14. Lessan K., Aguiar D.J., Oegema T., Siebenson L., Skubitz A.P.N. CD44 and β1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells. Am J Pathol. 154:1999;1525-1537.
15. Kishikawa T., Sakamoto M., Ino Y., Kubushiro K., Nozawa S., Hirohashi S. Two distinct patterns of peritoneal involvement shown by in vitro and in vivo ovarian cancer dissemination models. Invasion Metastasis. 15:1995;11-21.
16. Carreiras F., Denoux Y., Staedel C., Lehmann M., Sichel F., Gauduchon P. Expression and localization of αv integrins and their ligand vitronectin in normal ovarian epithelium and in ovarian carcinoma. Gynecol Oncol. 62:1996;260-267.
17. Liapis H., Adler L.M., Wick M.R., Rader J.S. Expression of αvβ3 integrin is less frequent in ovarian epithelial tumors of low malignant potential in contrast to ovarian carcinomas. Hum Pathol. 28:1997;443-449.
18. Skubitz A.P.N., Bast R.C. Jr, Wayner E.A., Letourneau P.C., Wilke M.S. Expression of α6 and β4 integrins in serous ovarian carcinoma correlates with expression of the basement membrane protein laminin. Am J Pathol. 148:1996;1445-1461.
19. Goldberg I., Davidson B., Reich R., Gotlieb W.H., Ben-Baruch G., Bryne M., et al. αV integrin is a novel marker of poor prognosis in advanced-stage ovarian carcinoma. Clin Cancer Res. 7:2001;4073-4079.
20. Davidson B., Nielsen S., Christensen J., Asschenfeldt P., Berner A., Risberg B., et al. The role of Desmin and N-cadherin in effusion cytology. A comparative study using established markers of mesothelial and epithelial cells. Am J Surg Pathol. 25:2001;1405-1412.
21. Davidson B., Risberg B., Kristensen G., Kvalheim G., Emilsen E., Bjåamer A., et al. Detection of cancer cells in effusions from patients diagnosed with gynecological malignancies - evaluation of five epithelial markers. Virchows Arch. 435:1999;43-49.
22. Young R.H., Clement P.B., Scully R.E. Surface epithelial-stromal tumors. Sternberg S.S., Antonioli D.A., Carter D., Mills S.E., Oberman H.A. Diagnostic surgical pathology. 1999;2319-2382 Lippincott Williams & Wilkins, Philadelphia.
23. Davidson B., Goldberg I., Gotlieb W.H., Kopolovic J., Ben-Baruch G., Nesland J.M., et al. High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma. Clin Exp Metastas. 17:1999;799-808.
24. Davidson B., Dong H.P., Berner A., Christensen J., Nielsen S., Johansen P., et al. Detection of malignant epithelial cells in effusions using flow cytometric immunophenotyping - an analysis of 92 cases. Am J Clin Pathol. 118:2002;85-92.
25. Davidson B., Reich R., Berner A., Givant-Horwitz V., Goldberg I., Risberg B., et al. Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels. Eur J Cancer. 37:2001;2040-2049.
26. Davidson B., Reich R., Kopolovic J., Berner A., Nesland J.M., Kristensen G.B., et al. Interleukin-8 and vascular endothelial growth factor mRNA levels are down-regulated in ovarian carcinoma cells in serous effusions. Clin Exp Metastas. 19:2002;135-144.
27. Davidson B, Goldberg I, Berner A, Kristensen GB, Reich R. EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma. Clin Exp Metastas 2003;20:161-9.
28. Shibata K., Kikkawa F., Nawa A., Suganuma N., Hamaguchi M. Fibronectin secretion from human peritoneal tissue induces Mr 92,000 type IV collagenase expression and invasion of ovarian cancer cell lines. Cancer Res. 57:1997;5416-5420.
29. Dauplat J., Hacker N.F., Nieberg R.K., Berek J.S., Rose T.P., Sagae S. Distant metastases in epithelial ovarian carcinoma. Cancer. 60:1987;1561-1566.
30. Berner H.S., Davidson B., Berner A., Risberg B., Kristensen G.B., Trope' C.G., et al. Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma - diagnostic and prognostic implications. Clin Exp Metastas. 18:2000;197-202.
31. Davidson B., Berner A., Nesland J.M., Risberg B., Kristensen G.B., Trope' C.G., et al. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma - evidence of up-regulated Tn and Sialyl Tn antigens expression in effusions. Hum Pathol. 31:2000;1081-1087.
32. Davidson B., Berner A., Nesland J.M., Risberg B., Berner H.S., Trope' C.G., et al. E-cadherin and α-, β- and γ-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions. J Pathol. 192:2000;460-469.
33. Davidson B., Goldberg I., Berner A., Nesland J.M., Givant-Horwitz V., Bryne M., et al. Expression of membrane-type 1,2 and 3 matrix metalloproteinases (MT1-MMP, MT2-MMP, MT3-MMP) mRNA in ovarian carcinoma cells in serous effusions. Am J Clin Pathol. 115:2001;517-524.
34. Davidson B., Risberg B., Berner A., Nesland J.M., Trope' C.G., Kristensen G.B., et al. Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions - biological and prognostic implications. Gynecol Oncol. 83:2001;249-256.
35. Davidson B., Lazarovici P., Ezersky A., Nesland J.M., Berner A., Risberg B., et al. Expression levels of the NGF receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients. Clin Cancer Res. 7:2001;3457-3464.
36. Davidson B., Risberg B., Goldberg I., Nesland J.M., Berner A., Trope' C.G., et al. Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome. Am J Surg Pathol. 25:2001;1493-1500.
37. Davidson B., Goldberg I., Givant-Horwitz V., et al. Caveolin-1 expression in ovarian carcinoma is MDR-1-independent. Am J Clin Pathol. 117:2002;225-234.
38. Davidson B., Goldberg I., Kopolovic J., Gotlieb W.H., Givant-Horwitz V., Nesland J.M., et al. Expression of angiogenesis-related genes in ovarian carcinoma - clinicopathologic study. Clin Exp Metastas. 18:2000;501-507.
39. Berditchevski F., Chang S., Bodorova J., Hemler M.E. Generation of monoclonal antibodies to integrin-associated proteins. J Biol Chem. 272:1997;29174-29180.